![Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study - The Lancet Microbe Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study - The Lancet Microbe](https://www.thelancet.com/cms/asset/5152bf79-6911-4c61-86ab-8068a3769305/gr1.jpg)
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study - The Lancet Microbe
![Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina - eClinicalMedicine Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina - eClinicalMedicine](https://www.thelancet.com/cms/asset/57ee42d7-62e3-4442-858e-e895eb8adcba/gr1.jpg)
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina - eClinicalMedicine
![Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden - The Lancet Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden - The Lancet](https://www.thelancet.com/cms/attachment/0e998800-4900-4087-87d1-0023588141e6/gr1.gif)
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden - The Lancet
![Healthcare | Free Full-Text | Using xPIRT to Record Pharmacy Interventions: An Observational, Cross-Sectional and Retrospective Study Healthcare | Free Full-Text | Using xPIRT to Record Pharmacy Interventions: An Observational, Cross-Sectional and Retrospective Study](https://www.mdpi.com/healthcare/healthcare-10-02450/article_deploy/html/images/healthcare-10-02450-g002.png)
Healthcare | Free Full-Text | Using xPIRT to Record Pharmacy Interventions: An Observational, Cross-Sectional and Retrospective Study
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak | PLOS ONE
![Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials - Annals of Oncology Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3f8b708f-33b2-41d5-9dac-57fd5b68ebf0/gr1.jpg)
Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials - Annals of Oncology
Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care: A retrospective study | PLOS ONE
![Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study - The Lancet Infectious Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study - The Lancet Infectious](https://www.thelancet.com/cms/attachment/454862d5-9a32-4762-95b0-9782de81b017/gr1.jpg)
Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study - The Lancet Infectious
![Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study - The Lancet Haematology Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study - The Lancet Haematology](https://www.thelancet.com/cms/attachment/845cfb8d-5da8-4a18-9647-c7a53bafee78/gr1.gif)
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study - The Lancet Haematology
![Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort | American Society of Nephrology Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/31/9/2205/F1.large.jpg)
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort | American Society of Nephrology
![Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study - The Lancet Infectious Diseases Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/f033291d-7de2-46f8-921c-e712fe555caa/gr1.gif)
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study - The Lancet Infectious Diseases
![Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/317aaed2-c7f0-447d-b7eb-7f70b276e4fe/gr1.jpg)
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine
![Adrenocorticotropic Hormone–Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies | Hypertension Adrenocorticotropic Hormone–Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies | Hypertension](https://www.ahajournals.org/cms/asset/e3867813-438a-48d0-848b-242554ebc031/hypertensionaha.121.17248.fig03.jpg)
Adrenocorticotropic Hormone–Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies | Hypertension
![WHO Eastern Mediterranean Regional Office (EMRO) on Twitter: "#COVID19 daily update in the World Health Organization (Eastern Mediterranean Regional Office) Region, as of 14 August 2022, 23:59 Cairo time #COVID19 ⬇️ https://t.co/MDEOMKRxp3" / WHO Eastern Mediterranean Regional Office (EMRO) on Twitter: "#COVID19 daily update in the World Health Organization (Eastern Mediterranean Regional Office) Region, as of 14 August 2022, 23:59 Cairo time #COVID19 ⬇️ https://t.co/MDEOMKRxp3" /](https://pbs.twimg.com/media/FaMl4_8WAAQBn1d.jpg)
WHO Eastern Mediterranean Regional Office (EMRO) on Twitter: "#COVID19 daily update in the World Health Organization (Eastern Mediterranean Regional Office) Region, as of 14 August 2022, 23:59 Cairo time #COVID19 ⬇️ https://t.co/MDEOMKRxp3" /
![Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 | MMWR Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7044e1_NaturalvsVaccineImmunity_IMAGE_29Oct21_1200x675.jpg)